publication . Article . 2016

To treat or not to treat: puberty suppression in childhood-onset gender dysphoria

Costa R; Carmichael P; Marco Colizzi;
  • Published: 19 Jul 2016
  • Country: United Kingdom
Abstract
<p>Puberty suppression using gonadotropin-releasing-hormone analogues (GnRHa) has become increasingly accepted as an intervention during the early stages of puberty (Tanner stage 2-3) in individuals with clear signs of childhood-onset gender dysphoria. However, lowering the age threshold for using medical intervention for children with gender dysphoria is still a matter of contention, and is more controversial than treating the condition in adolescents and adults, as children with gender dysphoria are more likely to express an unstable pattern of gender variance. Furthermore, concerns have been expressed regarding the risks of puberty suppression, which are poor...
Subjects
free text keywords: Urology, Endocrinology, medicine.medical_specialty, medicine, Gender dysphoria, medicine.disease, Sexual maturity, Informed consent, Gender variance, Internal medicine, Gender identity, Clinical psychology, Sexual dysfunction, medicine.symptom, business.industry, business, Safety criteria
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Article . 2016

To treat or not to treat: puberty suppression in childhood-onset gender dysphoria

Costa R; Carmichael P; Marco Colizzi;